BioAge Labs (BIOA) Research & Development (2023 - 2026)

BioAge Labs has disclosed Research & Development across 4 years of filings, most recently posting $24.4 million for Q2 2026.

• In Q2 2026, Research & Development rose 22.78% year-over-year to $24.4 million; the TTM figure through Jun 2026 stood at $87.8 million (up 25.06% YoY), while the FY2025 annual figure was $74.0 million, up 25.29% from the prior year.
• Research & Development came in at $24.4 million for Q2 2026 at BioAge Labs, up from $20.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $24.5 million in Q4 2025 to a low of $6.5 million in Q3 2023.
• Average Research & Development over 4 years is $16.2 million, with a median of $18.9 million recorded in 2024.
• Year-over-year, Research & Development surged 206.48% in 2024 and dropped 7.52% in 2025.
• Over 4 years, Research & Development stood at $10.1 million in 2023, then jumped by 90.69% to $19.2 million in 2024, then grew by 27.44% to $24.5 million in 2025, then fell by 0.55% to $24.4 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $24.4 million in Q2 2026, $20.4 million in Q1 2026, and $24.5 million in Q4 2025.